Recent News

• 02.25.2025 - ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
• 02.20.2025 - ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2024
• 01.16.2025 - ImmuCell Announces Settlement of Insurance Claim Related to Previously Disclosed Production Contamination Losses
• 01.09.2025 - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024
• 01.09.2025 - ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year 2024
• 11.13.2024 - ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2024
• 11.07.2024 - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
• 11.07.2024 - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2024
• 10.08.2024 - ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024

Recent Filings

• 02.25.2025 - 8-K Current report
• 02.25.2025 - EX-99.1 EX-99.1
• 01.16.2025 - EX-99.1 EX-99.1
• 01.16.2025 - 8-K Current report
• 01.10.2025 - 8-K Current report
• 12.09.2024 - 8-K Current report
• 12.02.2024 - 8-K Current report
• 11.13.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.13.2024 - EX-99.1 EX-99.1
• 11.13.2024 - 8-K Current report